Lisa Riley has described herself as a 'self-confessed control freak' as she revealed the reason why she has chosen not to ...
Announced positive data from Phase 1 clinical trial evaluating VG-3927 for potential treatment of Alzheimer's Disease (AD); plans to initiate Phase 2 clinical trial in Q3 2025 - - On track to report ...
Effective models could unlock some of what is still unknown in biology and help your doctor find the right treatment.